-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H/Z8sP3O0kzoCxnEYz96ANHQjHhTsaeuD5LNgX/mh6eGIf3QXehMl3PjjadVHMUP ZJlwYz70gFzuOLb1j2Yv7A== 0000875320-08-000028.txt : 20080521 0000875320-08-000028.hdr.sgml : 20080521 20080521153813 ACCESSION NUMBER: 0000875320-08-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080520 FILED AS OF DATE: 20080521 DATE AS OF CHANGE: 20080521 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRIMBLECOMBE ROGER W CENTRAL INDEX KEY: 0001197034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 08851829 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-05-20 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197034 BRIMBLECOMBE ROGER W C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2008-05-20 4 M 0 3333 14.20 A 3333 D Common Stock 2008-05-20 4 S 0 334 27.50 D 2999 D Common Stock 2008-05-20 4 S 0 333 27.58 D 2666 D Common Stock 2008-05-20 4 S 0 333 27.59 D 2333 D Common Stock 2008-05-20 4 S 0 333 27.61 D 2000 D Common Stock 2008-05-20 4 S 0 667 27.71 D 1333 D Common Stock 2008-05-20 4 S 0 333 27.73 D 1000 D Common Stock 2008-05-20 4 S 0 667 27.47 D 333 D Common Stock 2008-05-20 4 S 0 333 27.68 D 0 D Stock Option 14.20 2008-05-20 4 A 0 3333 0 D 1998-09-01 2008-05-31 Common Stock 3333 3333 D Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1. Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1998. Valerie L. Andrews, Attorney-In-Fact 2008-05-21 -----END PRIVACY-ENHANCED MESSAGE-----